Dexcom Phasing Out G6 System

Dexcom, Inc. announced the planned discontinuation of the Dexcom G6 Continuous Glucose Monitoring (CGM) System effective July 1, 2026. The discontinuation is part of a strategic transition to a new continuous glucose monitor (CGM), the Dexcom G7 and Dexcom G7 15 Day systems and is not related to a safety or quality issue. Production of Dexcom G6 systems and related components will cease by the end of June 2026, and availability cannot be guaranteed beginning July 1, 2026. However, existing inventory may remain available through the end of 2026. Dexcom will continue to honor prescription refills while supply lasts and provide technical support for in-warranty devices. The Dexcom G6 CGM System is FDA approved for CGM in patients aged two years and older with diabetes, including those with type 1, type 2 or gestational diabetes.